Skip to content
TrialScanner

NCT02302157

Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

Phase 1/Phase 2CompletedLCTXLead

Registry record

Lead sponsor
Lineage Cell Therapeutics, Inc.
Conditions
Cervical Spinal Cord Injury; Spine Injury; Spinal Cord Trauma
Primary completion
Dec 2018Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02302157 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02302157: Dose Escalation Study of... | TrialScanner